These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 428423)

  • 41. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arachidonic acid and pulmonary function in heart-lung-preparation of guinea-pig: modulation by PCO2.
    Bedetti C; Del Basso P; Argiolas L; Carpi A
    Arch Int Pharmacodyn Ther; 1987 Jan; 285(1):98-116. PubMed ID: 3107484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The importance of endogenous prostaglandins other than prostacyclin, for the modulation of contractility of some rabbit blood vessels.
    Förstermann U; Hertting G; Neufang B
    Br J Pharmacol; 1984 Apr; 81(4):623-30. PubMed ID: 6426568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material".
    Borda ES; Sterin-Borda L; Gimeno MF; Lazzari MA; Gimeno AL
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):79-89. PubMed ID: 6342559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mobilization of arachidonic acid in collagen-stimulated human platelets.
    Vedelago HR; Mahadevappa VG
    Biochem J; 1988 Dec; 256(3):981-7. PubMed ID: 3146982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of lung transit on systemic depressor responses to arachidonic acid and prostacyclin in dogs.
    Waldman HM; Alter I; Kot PA; Rose JC; Ramwell PW
    J Pharmacol Exp Ther; 1978 Feb; 204(2):289-93. PubMed ID: 340641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
    Shibata S; Ho WK; Ishida U
    J Pharmacol Exp Ther; 1980 Nov; 215(2):357-62. PubMed ID: 7441499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition by non-steroid anti-inflammatory agents of rabbit aorta contracting activity generated in blood by slow reacting substance C.
    Ferreira SH; Vargaftig BB
    Br J Pharmacol; 1974 Apr; 50(4):543-51. PubMed ID: 4155653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The tripeptide ZAMI-420 inhibits thromboxane-induced gastric vasoconstriction and ischaemia.
    Moroni D; Gervasi GB; Patella P; Visentin L; Maselli MA; Bergamaschi M
    Int J Tissue React; 1983; 5(3):249-52. PubMed ID: 6654624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modifications by endogenous prostaglandins of angiotensin II-induced contractions in dog and monkey cerebral and mesenteric arteries.
    Toda N; Ayaziki K; Okamura T
    J Pharmacol Exp Ther; 1990 Jan; 252(1):374-9. PubMed ID: 2299599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery.
    Mayeux PR; Kadowitz PJ; McNamara DB
    Biochim Biophys Acta; 1989 Mar; 1011(1):18-24. PubMed ID: 2493809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostacyclin release following endoperoxide analogue infusion in the intact dog.
    Mehta J; Nichols WW; Goldman R
    Am J Physiol; 1984 Feb; 246(2 Pt 2):R205-10. PubMed ID: 6364847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of hypoxia-induced contraction in human, monkey, and dog coronary arteries.
    Toda N; Matsumoto T; Yoshida K
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H678-83. PubMed ID: 1558175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator.
    Raz A; Isakson PC; Minkes MS; Needleman P
    J Biol Chem; 1977 Feb; 252(3):1123-6. PubMed ID: 838699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of arachidonic acid in the rabbit pulmonary and systemic vascular beds in vivo.
    el-Kashef HA; Catravas JD
    Pharmacology; 1990; 40(1):60-8. PubMed ID: 2109867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unstable metabolites of arachidonic acid aspirin and the formation of the haemostatic plug.
    Amezcua JL; Parsons M; Moncada S
    Thromb Res; 1978 Sep; 13(3):477-88. PubMed ID: 741441
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of certain herbal medicines on the biotransformation of arachidonic acid: a new pharmacological testing method using serum.
    Umeda M; Amagaya S; Ogihara Y
    J Ethnopharmacol; 1988; 23(1):91-8. PubMed ID: 3138504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of arachidonic acid modulation of the T-type Ca2+ channel alpha1G.
    Talavera K; Staes M; Janssens A; Droogmans G; Nilius B
    J Gen Physiol; 2004 Sep; 124(3):225-38. PubMed ID: 15314070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors.
    Okon EB; Golbabaie A; van Breemen C
    Br J Pharmacol; 2002 Oct; 137(4):545-53. PubMed ID: 12359637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.